EULAR 2016: Cardiovascular disease risk in rheumatoid arthritis is quite different from risk factors in the general population. Risk calculators should be different too, experts say.
EULAR 2016: Patient education and compliance often take a back seat to disease management, but they need to be at the forefront of care.
EULAR 2016: Secukinumab prevents radiographic progression in 80 percent of ankylosing spondylitis patients and provides sustained improvements.
EULAR 2016: Inflammatory bowel disease is commonly associated with psoriasis, psoriatic arthritis and ankylosing spondylitis.
EULAR 2016: A new study shows that patients with osteoarthritis may carry a greater burden of disease than patients with rheumatoid arthritis.
EULAR 2016: A new study shows an association between daily exposure to air pollutants and childhood-onset systemic lupus erythematous.
EULAR 2016: Ixekizumab significantly helped signs and symptoms of psoriatic arthritis in a phase 3 study reported this week.
EULAR 2016: Researchers have identified a potential predictive factor of failure by intra-articular injections of hyaluronic acid for knee osteoarthritis.
EULAR 2016: Rheumatoid arthritis patients with tenosynovitis respond better to ultrasound-guided peritendineus glucocorticoid injections as compared to intramuscular glucocorticoid injections.